(Photo = Guangdong Pharmaceutical)

 

[Alpha Biz= Reporter Kim Minyoung] Kwangdong Pharmaceutical announced on the 2nd that it has signed a stock trading contract to acquire Precision Biosensor, a company specializing in in vitro diagnostic devices.

Kwangdong Pharmaceutical plans to acquire 29.7% of shares held by Isens, the largest shareholder of Precision Biosensor, and the acquisition amount is about 17 billion won.

Precision Biosensor is a company specializing in in vitro diagnostic devices that manufacture and sell human · animal testers and cartridges.

 

 

[ⓒ AlphaBIZ. 무단전재-재배포 금지]